Advertisement

Topics

Teva CFO: We'll defend ourselves vigorously

08:49 EDT 12 May 2019 | Globes

Speaking at an Oppenheimer conference, Teva's Mike McClellan said the price-fixing allegations in the US were not new, and went on to describe the company's growth engines.

Original Article: Teva CFO: We'll defend ourselves vigorously

NEXT ARTICLE

More From BioPortfolio on "Teva CFO: We'll defend ourselves vigorously"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...